Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Sep;45(9):e70278.
doi: 10.1111/liv.70278.

C-Reactive Protein and Management of Hepatocellular Carcinoma: Bridging Systemic Inflammation and Clinical Prognosis

Stavros P Papadakos  1 , Alexandra Argyrou  1 , Elisavet Michailidou  1 , George V Papatheodoridis  1
Affiliations
Editorial

C-Reactive Protein and Management of Hepatocellular Carcinoma: Bridging Systemic Inflammation and Clinical Prognosis

Stavros P Papadakos et al. Liver Int. 2025 Sep.
No abstract available

PubMed Disclaimer

References

    1. B. Sangro, J. Argemi, M. Ronot, et al., “EASL Clinical Practice Guidelines on the Management of Hepatocellular Carcinoma,” Journal of Hepatology 82 (2025): 315–374.
    1. M. Reig, A. Forner, J. Rimola, et al., “BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update,” Journal of Hepatology 76 (2022): 681–693.
    1. A. Papatheodoridi and G. Papatheodoridis, “Hepatocellular Carcinoma: The Virus or the Liver?,” Liver International 43 (2022): 22–30, https://doi.org/10.1111/liv.15253.
    1. F. Copil, C. Campani, M. Lequoy, et al., “No Correlation Between MASLD and Poor Outcome of Atezolizumab‐Bevacizumab Therapy in Patients With Advanced HCC,” Liver International 44 (2024): 931–943.
    1. S. P. Papadakos, N. Dedes, E. Kouroumalis, and S. Theocharis, “The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity,” Cancers 14 (2022): 3150.

Publication types

LinkOut - more resources